Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.

BACKGROUND Inflammatory bowel disease (IBD) is associated with a high risk of venous thromboembolism (VTE) during hospitalization. It is unclear if this association persists after discharge. We aimed to assess the incidence of postdischarge VTE in IBD patients and to determine if IBD is associated with increased VTE risk. METHODS We performed a population-based cohort study between 2002 and 2016 using Ontario health administrative data sets. Hospitalized (≥72 hours) adults with IBD were stratified into nonsurgical and surgical cohorts and matched on propensity score to non-IBD controls. Time to postdischarge VTE was assessed by Kaplan-Meier methods, and VTE risk was assessed by Cox proportional hazard models. RESULTS A total of 81,900 IBD discharges (62,848 nonsurgical and 19,052 surgical) were matched to non-IBD controls. The cumulative incidence of VTE at 12 months after discharge was 2.3% for nonsurgical IBD patients and 1.6% for surgical IBD patients. The incidence increased in the nonsurgical IBD cohort by 4% per year (incidence rate ratio, 1.04; 95% CI, 1.02-1.05). In our propensity score-matched analysis, the risk of VTE at 1-month postdischarge was greater in nonsurgical IBD patients (hazard ratio [HR], 1.72; 95% CI, 1.51-1.96) and surgical patients with ulcerative colitis (HR, 1.68; 95% CI, 1.16-2.45) but not surgical patients with Crohn's disease. These trends persisted through 12 months. CONCLUSIONS Nonsurgical IBD patients and surgical patients with ulcerative colitis are 1.7-fold more likely to develop postdischarge VTE than non-IBD patients. These findings support the need for increased vigilance and consideration of thromboprophylaxis in this population.

[1]  Jason D. Wright,et al.  Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  T. Ramsay,et al.  A clinical predictive model for post‐hospitalisation venous thromboembolism in patients with inflammatory bowel disease , 2019, Alimentary pharmacology & therapeutics.

[3]  T. Card,et al.  The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity , 2018, Alimentary pharmacology & therapeutics.

[4]  J. Wong,et al.  Incidence and Risk Factor Analysis of Thromboembolic Events in East Asian Patients With Inflammatory Bowel Disease, a Multinational Collaborative Study. , 2018, Inflammatory bowel diseases.

[5]  M. Di Nisio,et al.  Incidental venous thromboembolism: is anticoagulation indicated? , 2017, Hematology. American Society of Hematology. Education Program.

[6]  Subrata Ghosh,et al.  Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study , 2017, The American Journal of Gastroenterology.

[7]  M. Berry,et al.  Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies , 2017, Journal of the National Cancer Institute.

[8]  F. Klok,et al.  Management of incidental pulmonary embolism , 2017, European Respiratory Journal.

[9]  D. Baird,et al.  Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis , 2016, Inflammatory bowel diseases.

[10]  P. Higgins,et al.  Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  G. Kaplan,et al.  Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. , 2015, World journal of gastroenterology.

[12]  A. Forster,et al.  Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada. , 2014, Journal of clinical epidemiology.

[13]  L. Dauchet,et al.  Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. , 2014, Journal of Crohn's & colitis.

[14]  A. Griffiths,et al.  Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. , 2014, Gastroenterology.

[15]  Elizabeth A. Scoville,et al.  Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  H. Yuhara,et al.  Meta‐analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.

[17]  G. Kaplan,et al.  Postoperative complications following colectomy for ulcerative colitis: A validation study , 2012, BMC Gastroenterology.

[18]  A. Griffiths,et al.  Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements , 2012, The American Journal of Gastroenterology.

[19]  L. Tamariz,et al.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data , 2012, Pharmacoepidemiology and Drug Safety.

[20]  P. Austin An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[21]  G. Nguyen,et al.  Venous Thromboembolism in Inflammatory Bowel Disease: An Epidemiological Review , 2011, The American Journal of Gastroenterology.

[22]  J. West,et al.  Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study , 2010, The Lancet.

[23]  H. Tilg,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. , 2010, Journal of Crohn's & colitis.

[24]  T. To,et al.  Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data , 2009, Gut.

[25]  Justina J. Sam,et al.  Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[26]  G. Kaplan,et al.  A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[27]  C. Huerta,et al.  Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.

[28]  S. Danese,et al.  Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.

[29]  P. Austin,et al.  The use of the propensity score for estimating treatment effects: administrative versus clinical data , 2005, Statistics in medicine.

[30]  W. Reinisch,et al.  Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? , 2004, Gut.

[31]  I. Brandslund,et al.  Markers of Coagulation and Fibrinolysis as Measures of Disease Activity in Inflammatory Bowel Disease , 1998 .